More bankruptcies will affect exports

The expected rise in overseas companies going bankrupt in 2006 will affect Israeli exporters, the Israeli Credit Insurance Company (ICIC) said Tuesday.

By AVI KRAWITZ
December 28, 2005 07:46

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The expected rise in overseas companies going bankrupt in 2006 will affect Israeli exporters, the Israeli Credit Insurance Company (ICIC) said Tuesday. ICIC warned that it expects a change in the recent downward trend of international bankruptcies, which would also affect customers of Israeli exporters. Bankruptcies dropped in the US by 2% in 2004 and a further percent this year but the ICIC said it expects 3% growth in the number of companies filing for Chapter 11 in 2006. The same trend was forecast for Europe and the Far east.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS